Weight loss drug Ozempic sales grow nearly 50% in the US, says maker Novo Nordisk
A surge in demand for weight loss drug has helped Novo Nordisk post a 25% jump in revenues in the first half of the year, the Danish company said today.
A surge in demand for weight loss drug has helped Novo Nordisk post a 25% jump in revenues in the first half of the year, the Danish company said today.